A Comparative Study of Fuzzy Classifiers on Breast Cancer Data

2003 ◽  
pp. 512-519 ◽  
Author(s):  
Ravi. Jain ◽  
Ajith. Abraham
Keyword(s):  
Breast Cancer ◽  
Comparative Study ◽  
Breast Cancer Data ◽  
Cancer Data ◽  
Fuzzy Classifiers

Bayesian Frailty Model for Time to Event Breast Cancer Data

2011 ◽  
Vol 4 (2) ◽  
pp. 8-12
Author(s):  
Leo Alexander T Leo Alexander T ◽  
◽  
Pari Dayal L Pari Dayal L ◽  
Valarmathi S Valarmathi S ◽  
Ponnuraja C Ponnuraja C ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Frailty Model ◽  
Breast Cancer Data ◽  
Time To Event ◽  
Cancer Data

AGE FEATURES OF MOLECULAR-BIOLOGICAL SUBTYPES OF BREAST CANCER IN THE REPUBLIC OF UZBEKISTAN

2018 ◽  
Vol 64 (2) ◽  
pp. 196-199
Author(s):  
Gulya Miryusupova ◽  
G. Khakimov ◽  
N. Shayusupov
Keyword(s):  
Breast Cancer ◽  
Cancer Care ◽  
Indigenous Women ◽  
Morbidity And Mortality ◽  
Breast Cancer Data ◽  
Female Population ◽  
Cancer Data ◽  
Age Related ◽  
The Republic ◽  
Age Features

According to the results of breast cancer data in the Republic of Uzbekistan in addition to the increase in morbidity and mortality from breast cancer among women the presence of age specific features among indigenous women in the direction of “rejuvenating” of the disease with all molecular-biological (phenotypic) subtypes of breast cancer were marked. Within the framework of age-related features the prevalence of the least favorable phenotypes of breast cancer was found among indigenous women: Her2/neu hyperexpressive and three times negative subtype of breast cancer. The data obtained made it possible to build a so-called population “portrait” of breast cancer on the territory of the Republic, which in turn would contribute to further improvement of cancer care for the female population of the country.

Genetics testing firm is accused of "hiding vital breast cancer data"

BMJ ◽  
2012 ◽  
Vol 345 (nov01 2) ◽  
pp. e7402-e7402
Author(s):  
N. Hawkes
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Data ◽  
Cancer Data

Screening Breast MRI and Gadolinium Deposition: Cause for Concern?

2021 ◽  
Author(s):  
Colleen H Neal
Keyword(s):  
Breast Cancer ◽  
Renal Function ◽  
Contrast Agents ◽  
Biological Significance ◽  
Breast Mri ◽  
Reliable Data ◽  
Breast Cancer Data ◽  
Cancer Data ◽  
Contrast Enhanced ◽  
Gadolinium Retention

Abstract Gadolinium-based contrast agents (GBCAs) have been used worldwide for over 30 years and have enabled lifesaving diagnoses. Contrast-enhanced breast MRI is frequently used as supplemental screening for women with an elevated lifetime risk of breast cancer. Data have emerged that indicate a fractional amount of administered gadolinium is retained in the bone, skin, solid organs, and brain tissues of patients with normal renal function, although there are currently no reliable data regarding the clinical or biological significance of this retention. Linear GBCAs are associated with a higher risk of gadolinium retention than macrocyclic agents. Over the course of their lives, screened women may receive high cumulative doses of GBCA. Therefore, as breast MRI screening utilization increases, thoughtful use of GBCA is indicated in this patient population.

Sign in / Sign up

Export Citation Format

Share Document